Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2013 1
2014 1
2015 2
2018 1
2019 6
2020 4
2021 6
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis.
Bewersdorf JP, Giri S, Wang R, Podoltsev N, Williams RT, Rampal RK, Tallman MS, Zeidan AM, Stahl M. Bewersdorf JP, et al. Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e712-e723. doi: 10.1016/j.clml.2020.05.018. Epub 2020 May 28. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32669244 Free PMC article.
Myelofibrosis: best practices, controversies and 2019 update.
Cruz NM, Gergis U, Silver RT. Cruz NM, et al. Expert Rev Hematol. 2020 Jan;13(1):71-84. doi: 10.1080/17474086.2020.1691519. Epub 2019 Nov 30. Expert Rev Hematol. 2020. PMID: 31709843
The authors conducted a systematic literature review to answer questions regarding differences between primary myelofibrosis (PMF) and secondary myelofibrosis (SMF), appropriate use and selection of the current risk-stratification models, early versus late treatment …
The authors conducted a systematic literature review to answer questions regarding differences between primary myelofibrosis ( …
Osteolytic bone lesions in patients with primary myelofibrosis: A systematic review.
Battukh N, Ali E, Yassin M. Battukh N, et al. Acta Biomed. 2022 Jan 19;92(6):e2021478. doi: 10.23750/abm.v92i6.12350. Acta Biomed. 2022. PMID: 35075062 Free PMC article.
They include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Among this group, primary myelofibrosis is the least common and usually carries the worst prognosis. Bone involvement in primary myelofibrosis has many …
They include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Among this group, primary myel
Inheritance of the chronic myeloproliferative neoplasms. A systematic review.
Ranjan A, Penninga E, Jelsig AM, Hasselbalch HC, Bjerrum OW. Ranjan A, et al. Clin Genet. 2013 Feb;83(2):99-107. doi: 10.1111/cge.12044. Epub 2012 Nov 20. Clin Genet. 2013. PMID: 23094849 Review.
This systematic review investigated the inheritance of the classical chronic myeloproliferative neoplasms (MPNs) including polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF) and chronic myelogenous leukemia (CML). ...
This systematic review investigated the inheritance of the classical chronic myeloproliferative neoplasms (MPNs) including polycythemia vera …
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.
Kröger NM, Deeg JH, Olavarria E, Niederwieser D, Bacigalupo A, Barbui T, Rambaldi A, Mesa R, Tefferi A, Griesshammer M, Gupta V, Harrison C, Alchalby H, Vannucchi AM, Cervantes F, Robin M, Ditschkowski M, Fauble V, McLornan D, Ballen K, Popat UR, Passamonti F, Rondelli D, Barosi G. Kröger NM, et al. Leukemia. 2015 Nov;29(11):2126-33. doi: 10.1038/leu.2015.233. Epub 2015 Aug 21. Leukemia. 2015. PMID: 26293647 Review.
The aim of this work is to produce recommendations on the management of allogeneic stem cell transplantation (allo-SCT) in primary myelofibrosis (PMF). A comprehensive systematic review of articles released from 1999 to 2015 (January) was used as a source of scienti …
The aim of this work is to produce recommendations on the management of allogeneic stem cell transplantation (allo-SCT) in primary
23 results